[{"authors": [{"affiliation": [], "given": "Asbj\u00f8rn", "family": "Mack"}], "doi": "10.5639/gabij.2015.0402.018", "title": "Norway, biosimilars in different funding systems. What works?", "journal": "Generics and Biosimilars Initiative Journal", "year": "2015-6", "cite": "11", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Valderilio Feij\u00f3", "family": "Azevedo"}, {"affiliation": [], "given": "Eduardo", "family": "Mysler"}, {"affiliation": [], "given": "Alexis Aceituno", "family": "\u00c1lvarez"}, {"affiliation": [], "given": "Juana", "family": "Hughes"}, {"affiliation": [], "given": "Francisco Javier", "family": "Flores-Murrieta"}, {"affiliation": [], "given": "Eva Maria", "family": "Ruiz de Castilla"}], "doi": "10.5639/gabij.2014.0303.032", "title": "Recommendations for the regulation of biosimilars and their implementation in Latin America", "journal": "Generics and Biosimilars Initiative Journal", "year": "2014-9", "cite": "10", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "George", "family": "Karpetis"}], "doi": "10.1080/02650533.2015.1050653", "title": "Psychoanalytic insights and empowerment in social work practice: evaluating the effectiveness of the \u2018transference interpretation to the setting\u2019 technique", "journal": "Journal of Social Work Practice", "year": "2015-7", "cite": "6", "pub": "Informa UK Limited", "issn": "0265-0533"}, {"authors": [{"affiliation": [], "given": "Agnes V", "family": "Klein"}, {"affiliation": [], "given": "Jian", "family": "Wang"}, {"affiliation": [], "given": "Patrick", "family": "Bedford"}], "doi": "10.5639/gabij.2014.0303.033", "title": "Subsequent entry biologics (biosimilars) in Canada: approaches to interchangeability and the extrapolation of indications and uses", "journal": "Generics and Biosimilars Initiative Journal", "year": "2014-9", "cite": "5", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Falk", "family": "Ehmann"}, {"affiliation": [], "given": "Ruben", "family": "Pita"}], "doi": "10.5639/gabij.2016.0501.008", "title": "The EU is ready for non-biological complex medicinal products", "journal": "Generics and Biosimilars Initiative Journal", "year": "2016-3", "cite": "5", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Arti", "family": "Appannah"}, {"affiliation": [], "given": "Simon", "family": "Biggs"}], "doi": "10.1080/02650533.2014.993943", "title": "Age-Friendly Organisations: The Role of Organisational Culture and the Participation of Older Workers", "journal": "Journal of Social Work Practice", "year": "2015-1", "cite": "5", "pub": "Informa UK Limited", "issn": "0265-0533"}, {"authors": [{"affiliation": [], "name": "European Biopharmaceutical Enterprises"}], "doi": "10.5639/gabij.2015.0401.006", "title": "What pricing and reimbursement policies to use for off-patent biologicals? \u2013 Results from the EBE 2014 biological medicines policy survey", "journal": "Generics and Biosimilars Initiative Journal", "year": "2015-3", "cite": "5", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Joshua P", "family": "Cohen"}, {"affiliation": [], "given": "Abigail E", "family": "Felix"}, {"affiliation": [], "given": "Kim", "family": "Riggs"}, {"affiliation": [], "given": "Anumeha", "family": "Gupta"}], "doi": "10.5639/gabij.2014.0303.028", "title": "Barriers to market uptake of biosimilars in the US", "journal": "Generics and Biosimilars Initiative Journal", "year": "2014-9", "cite": "4", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Wenjie", "family": "Zeng"}, {"affiliation": [], "given": "Houmei", "family": "Xi"}, {"affiliation": [], "given": "Brian", "family": "Godman"}, {"affiliation": [], "given": "Alexander E", "family": "Finlayson"}, {"affiliation": [], "given": "Rickard E", "family": "Malmstrom"}], "doi": "10.5639/gabij.2014.0303.030", "title": "Ongoing initiatives to improve prescribing efficiency in China; statins as a case history", "journal": "Generics and Biosimilars Initiative Journal", "year": "2014-9", "cite": "4", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Simon", "family": "Biggs"}, {"affiliation": [], "given": "Ashley", "family": "Carr"}], "doi": "10.1080/02650533.2014.993942", "title": "Age- and Child-Friendly Cities and the Promise of Intergenerational Space", "journal": "Journal of Social Work Practice", "year": "2015-1", "cite": "4", "pub": "Informa UK Limited", "issn": "0265-0533"}, {"authors": [{"affiliation": [], "given": "Thibauld", "family": "Moulaert"}, {"affiliation": [], "given": "Suzanne", "family": "Garon"}], "doi": "10.1080/02650533.2014.993946", "title": "Researchers Behind Policy Development: Comparing \u2018Age-Friendly Cities\u2019 Models in Quebec and Wallonia", "journal": "Journal of Social Work Practice", "year": "2015-1", "cite": "3", "pub": "Informa UK Limited", "issn": "0265-0533"}, {"authors": [{"affiliation": [], "given": "Vito", "family": "Annese"}, {"affiliation": [], "given": "Cristina", "family": "Avenda\u00f1o-Sol\u00e1"}, {"affiliation": [], "given": "Ferdinand", "family": "Breedveld"}, {"affiliation": [], "given": "Niklas", "family": "Ekman"}, {"affiliation": [], "given": "Thijs J", "family": "Giezen"}, {"affiliation": [], "given": "Fernando", "family": "Gomoll\u00f3n"}, {"affiliation": [], "given": "Pekka", "family": "Kurki"}, {"affiliation": [], "given": "Tore Kristian", "family": "Kvien"}, {"affiliation": [], "given": "Andrea", "family": "Laslop"}, {"affiliation": [], "given": "Llu\u00eds", "family": "Puig"}, {"affiliation": [], "given": "Robin", "family": "Thorpe"}, {"affiliation": [], "given": "Martina", "family": "Weise"}, {"affiliation": [], "given": "Elena", "family": "Wolff-Holz"}], "doi": "10.5639/gabij.2016.0502.019", "title": "Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016", "journal": "Generics and Biosimilars Initiative Journal", "year": "2016-6", "cite": "3", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Ally", "family": "Pen"}, {"affiliation": [], "given": "Agnes V", "family": "Klein"}, {"affiliation": [], "given": "Jian", "family": "Wang"}], "doi": "10.5639/gabij.2015.0401.009", "title": "Health Canada\u2019s perspective on the clinical development of biosimilars and related scientific and regulatory challenges", "journal": "Generics and Biosimilars Initiative Journal", "year": "2015-3", "cite": "3", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "family": "GaBI Journal Editor"}], "doi": "10.5639/gabij.2015.0404.040", "title": "Patent expiry dates for best-selling biologicals", "journal": "Generics and Biosimilars Initiative Journal", "year": "2015-12", "cite": "3", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "family": "European Biopharmaceutical Enterprises"}, {"affiliation": [], "given": "Keith", "family": "Watson"}, {"affiliation": [], "given": "Virginia", "family": "Acha"}, {"affiliation": [], "given": "Alexander", "family": "Roediger"}, {"affiliation": [], "given": "\u00c5sa", "family": "Rembratt"}, {"affiliation": [], "given": "Edward", "family": "Hume"}, {"affiliation": [], "given": "Fabio", "family": "Bisordi"}, {"affiliation": [], "given": "Marloes", "family": "van Bruggen"}], "doi": "10.5639/gabij.2014.0304.043", "title": "Tell me the whole story: the role of product labelling in building user confidence in biosimilars in Europe", "journal": "Generics and Biosimilars Initiative Journal", "year": "2014-12", "cite": "3", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Brian", "family": "Godman"}, {"affiliation": [], "given": "Hye-Young", "family": "Kwon"}, {"affiliation": [], "given": "Ljiljana Sovi\u0107", "family": "Brki\u010di\u0107"}, {"affiliation": [], "given": "Martina", "family": "Bogut"}, {"affiliation": [], "given": "Miron", "family": "Sr\u0161en"}, {"affiliation": [], "given": "Tonko", "family": "Tabain"}, {"affiliation": [], "given": "Winnie de", "family": "Bruyn"}], "doi": "10.5639/gabij.2015.0402.017", "title": "Pharmaceutical pricing in Croatia: a comparison of ordinances in 2013 versus 2009 and their potential savings to provide future guidance", "journal": "Generics and Biosimilars Initiative Journal", "year": "2015-6", "cite": "2", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Robert", "family": "Janknegt"}, {"affiliation": [], "given": "Niels", "family": "Boone"}, {"affiliation": [], "given": "Frans", "family": "Erdkamp"}, {"affiliation": [], "given": "Victor", "family": "Zambon"}], "doi": "10.5639/gabij.2014.0303.031", "title": "GnRH agonists and antagonists in prostate cancer", "journal": "Generics and Biosimilars Initiative Journal", "year": "2014-9", "cite": "2", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Pekka", "family": "Kurki"}], "doi": "10.5639/gabij.2015.0401.008", "title": "Biosimilars for prescribers", "journal": "Generics and Biosimilars Initiative Journal", "year": "2015-3", "cite": "2", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}, {"authors": [{"affiliation": [], "given": "Robyn", "family": "Lynn"}, {"affiliation": [], "given": "Jo", "family": "Mensinga"}], "doi": "10.1080/02650533.2015.1035237", "title": "Social Workers' Narratives of Integrating Mindfulness into Practice", "journal": "Journal of Social Work Practice", "year": "2015-4", "cite": "2", "pub": "Informa UK Limited", "issn": "0265-0533"}, {"authors": [{"affiliation": [], "given": "Alan", "family": "Lyles"}], "doi": "10.5639/gabij.2015.0401.002", "title": "Biosimilars: patient and physician acceptability is the fifth hurdle to market competition", "journal": "Generics and Biosimilars Initiative Journal", "year": "2015-3", "cite": "2", "pub": "Pro Pharma Communications International", "issn": "2033-6403"}]